Anscheinend steigen einige institutionelle Anleger ein und so ganz gräuschlos geht das nicht bei so einem marktengen Wert.
Der Artikel zur Namensänderung:
Harris & Harris Group Proposes Name Change To Small-Technology
Venture Capital, Inc.
TUESDAY, MARCH 26, 2002 3:57 PM
NEW YORK, Mar 26, 2002 (BUSINESS WIRE) -- Harris & Harris Group, Inc.
(NASDAQ/NMS SYMBOL: HHGP) announced today that its board of directors will submit to
shareholders for approval at the 2002 Annual Meeting a proposal to change the name of the
Company to Small-Technology Venture Capital, Inc.
The date of the 2002 Annual Meeting has not been set.
The Company's management and board believes that the name, "Small-Technology Venture
Capital, Inc.," now best describes the Company's business. The Company will continue to
function as a publicly traded venture capital firm specializing in early-stage, high technology
companies commercializing proprietary intellectual property. But earlier in 2002, the
Company announced that it will now focus its new business activities exclusively on small
technology (small tech), including nanotechnology, microsystems and
microelectromechanical systems (MEMS).
In 1994, the Company invested in its first small-tech company, Nanophase Technologies
Corporation, a spinoff from Argonne National Laboratory, which subsequently completed an
initial public offering in 1997. The Company sold its interest in Nanophase in 2001 and
invested part of the proceeds of the sale in August, 2001, in privately held Nantero, Inc., a
Harvard University spinoff developing advanced memory devices using carbon nanotubes. In
February, 2002, the Company invested in privately held Nanopharma Corp., a research-based
Massachusetts General Hospital spinoff founded to develop advanced drug delivery systems.
On March 13, 2002, the Company also noted its investment in NEO Photonics Corporation,
a privately held producer of novel materials compositions to enable a unique optical
integration platform. In March, 2002, the Company also elected two new directors to its
board, Dr. Kelly S. Kirkpatrick and Lori D. Pressman, whose professional backgrounds are
particularly well suited to the Company's small-tech focus.